Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

SPRO

Spero Therapeutics, Inc.

CIK 0001701108 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$1.22
↑ 0.01 (0.83%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Technicals; Excluded: Options (no data)

Key stats

Market Cap
$71.05M
P/E Ratio
9.62
EPS
0.15
Dividend Yield
Not covered
52W Position
7%
Beta
1.47

Valuation multiples

Fwd P/E
Not covered
PEG
0.00
P/B
1.61
P/S
1.51
EV/Revenue
0.43
ROE
16.7%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 7%
$1.08$3.08

Latest Financials

2025-12-31 FY
Revenue
$66.80M
Net Income
$8.57M
Total Assets
$68.92M
Free Cash Flow
–

Recent news